FDG PET/CT in peritoneal metastasis from prostate cancer
Künye
Gungor, S., Asa, S., Kupik, O. (2016). FDG PET/CT in peritoneal metastasis from prostate cancer. Clinical Nuclear Medicine, 41(9), E424-E425. https://doi.org/10.1097/RLU.0000000000001256Özet
Prostate cancer is one of the leading causes of cancer death in men. the prognosis in prostate cancer is greatly worsened by the presence of metastases, which are most commonly found in bone, lung, liver, and brain. the peritoneum is an extremely uncommon metastatic site for prostate cancer, even in autopsy series. We present a case of FDG PET/CT demonstration of peritoneal metastasis from prostate cancer.